title: Polyglutamine is not all: the functional role of the AXH domain in the ataxin-1 protein.
abstract: A family of neurodegenerative diseases is associated with anomalous expansion of a polyglutamine tract in the coding region of the corresponding proteins. The current working hypothesis is that polyglutamine diseases are caused by misfolding and aggregation of the proteins with a process dictated by the polyglutamine tracts, although increasing evidence suggests an involvement of the protein context in modulating these properties. Here, we show that the AXH domain of ataxin-1, the protein involved in spinocerebellar ataxia type-1, is the region responsible for the transcriptional repression activity of ataxin-1 and participates in protein aggregation. In vitro, the isolated domain undergoes a conformational transition towards a beta-enriched structure associated with aggregation and amyloid fibre formation spontaneously and without need for destabilizing conditions. Using a transfected cell line, we demonstrate that, while determined by polyglutamine expansion, ataxin-1 aggregation is noticeably reduced by deletion of AXH or by replacement with the homologous sequence from the transcription factor HBP1, which has no known tendency to aggregate. These results provide the first direct evidence of an involvement of a region other than the polyglutamine tract in polyglutamine pathologies.
authors.affiliation: National Institute for Medical Research, The Ridgeway, London NW71AA, UK.
authors.forename: Cesira
authors.initials: C
authors.lastname: de Chiara
authors.forename: Rajesh P
authors.initials: RP
authors.lastname: Menon
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Dal Piaz
authors.forename: Lesley
authors.initials: L
authors.lastname: Calder
authors.forename: Annalisa
authors.initials: A
authors.lastname: Pastore
mesh_terms: D000682:Amyloid; D000818:Animals; D000067528:Ataxins; D019556:COS Cells; D002522:Chlorocebus aethiops; D019281:Dimerization; D005786:Gene Expression Regulation; D009419:Nerve Tissue Proteins / Q000737:chemistry* / Q000378:metabolism*; D019636:Neurodegenerative Diseases / Q000209:etiology; D009687:Nuclear Proteins / Q000737:chemistry* / Q000378:metabolism*; D010455:Peptides / Q000378:metabolism / Q000502:physiology; D017434:Protein Structure, Tertiary; D012097:Repressor Proteins; D013696:Temperature; D014162:Transfection
chemical_list: D000682:Amyloid; D000067528:Ataxins; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D010455:Peptides; D012097:Repressor Proteins; C097188:polyglutamine